OR WAIT null SECS
Click here to read the articles and download the PDF
A conversation with Matthew Bardell, managing director, nVentic, about a perhaps overlooked but useful strategic component of company performance and overall business benchmarks: inventory optimization.
Making sense of the accelerating trends and challenges—including store closings, pharmacy deserts, and the rise of polypharmacy.
Even as pharma technology evolves, and payers argue over reimbursement practices throughout healthcare, drug wholesaling is a thriving business.
November 14, 2023
Stephanie L. Woerner, PhD, director and principal research scientist at the MIT Center for Information Systems Research, discusses the outlook for next year among biopharma firms.
Bayer said it will explore access options for patients with follicular lymphoma currently receiving Aliqopa who have experienced a favorable response to treatment.
November 13, 2023
JMA Journal report describes how businesses in this Asian-Pacific nation are employing various strategies to reduce GHG emissions.
A demand-driven methodology for data standardization across multiple streams of acquisition could improve the sharing of real-world data worldwide.
Exparel was initially approved in 2011 for single-dose infiltration into a surgical site.
November 10, 2023
The Flowflex COVID-19 Antigen Home Test is the first over-the-counter rapid antigen test for SARS-CoV-2 to gain FDA 510(k) marketing clearance by the FDA.
Blue Fin Group exec speaks on his upcoming feature.
New E2E workflow orchestration service is expected to simplify the processes of health systems and retail pharmacies while also reducing the risk of recalled items reaching patients.
Financial commitment further strengthens IntegriChain’s platform as a source for pharma manufacturers' commercialization and market access goals.
November 09, 2023
Blue Fin Group executive highlights how leaders can plan for immediate profitable lifecycles and beyond.